Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and TBS for Cocaine Cue Reactivity
NCT04155632Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in cocaine use disorder (CUD) (4 arms), sponsored by Medical University of South Carolina. Primary endpoints: Change in Orbitofrontal Cortex (OFC) BOLD Signal During Cocaine Cue Reactivity Task, Change in Profile of Mood States (POMS) Score and 1 more. Started Dec 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT04155632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155632.